Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 21 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

2 trials in Phase 3/4

Results Transparency

17%

2 of 12 completed trials have results

Key Signals

5 recruiting2 with results

Enrollment Performance

Analytics

N/A

15(83.3%)

Phase 4

2(11.1%)

Phase 2

1(5.6%)

18Total

N/A(15)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials

NCT07554690Not ApplicableNot Yet Recruiting

Photobiomodulation Laser for Reticular Pseudodrusen in Age-Related Macular Degeneration

Role: lead

NCT07500324Not ApplicableRecruiting

Proteomic Biomarker Identification in AMD, Diabetic Retinopathy and Retinal Detachment

Role: lead

NCT05793515Completed

Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models

Role: collaborator

NCT06906003Recruiting

Visual Rehabilitation and Depression in Visually Impaired Patients with AMD

Role: lead

NCT04847635Not ApplicableRecruiting

Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration

Role: collaborator

NCT06278597Not ApplicableCompleted

Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device

Role: lead

NCT05976139Not ApplicableRecruiting

Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies

Role: lead

NCT06227611Recruiting

Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients with Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.

Role: lead

NCT05315206Not ApplicableActive Not Recruiting

Multimodal Morpho-functional Study in Glaucoma Patients-Citicoline Oral Solution

Role: lead

NCT03758118Not ApplicableCompleted

Citicoline in Non-Arteritic Ischemic Optic Neuropathy

Role: lead

NCT05299593Phase 4Unknown

24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.

Role: lead

NCT00404729Phase 4Completed

Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases

Role: lead

NCT04135638Not ApplicableUnknown

Inverted ILM-flap Techniques Variants for Macular Hole Surgery: Outcomes Comparison

Role: collaborator

NCT02117999Not ApplicableCompleted

Transepithelial Corneal Cross-linking Using Iontophoresis

Role: lead

NCT03598205Not ApplicableCompleted

Curcumin and Intravitreal Dexamethasone in Diabetic Macular Edema

Role: lead

NCT04009980Not ApplicableCompleted

Long-term Retinal Changes After Topical Citicoline Administration in Patients With Mild Signs of Diabetic Retinopathy in Type 1 Diabetes Mellitus.

Role: lead

NCT04003090Not ApplicableCompleted

Citicoline Concentration in Human Vitreous

Role: collaborator

NCT03919019Not ApplicableCompleted

Morpho-functional Changes After Oral Supplementation of Antioxidants and Anti-inflammatory Treatment in Age-Related Macular Degeneration.

Role: lead

NCT03480295Not ApplicableCompleted

Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%

Role: lead

NCT03398109Not ApplicableCompleted

Effectiveness of Toric Intraocular Lenses for Treating Corneal Astigmatism in Patients With Cataract and Previous DALK

Role: lead